Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DE2WS7
|
|||
| Drug Name |
GT005
|
|||
| Synonyms |
PPY988
Click to Show/Hide
|
|||
| Indication | Geographic atrophy [ICD-11: 9B75] | Phase 2 | [1] | |
| Company |
Novartis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04566445) HORIZON: A Phase II, Open-label, Outcomes-assessor Masked, Multicentre, Randomised, Controlled Study to Evaluate the Safety and Efficacy of Two Doses of GT005 Administered as a Single Subretinal Injection in Subjects With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.